The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2021
Note 1 – Summary of Significant Accounting Policies
Business Overview
Hawkeye Systems, Inc. (“the Company”), a Nevada corporation incorporated on May 15, 2018, is a technology holding company evaluating strategic alternatives.
Basis of presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.
In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited condensed consolidated financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended June 30, 2021, as filed with the SEC on October 13, 2021.
Use of estimates
The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. Significant estimates in the accompanying financial statements include useful lives of property and equipment, fair value assumptions used for stock-based compensation, valuation of beneficial conversion feature on convertible notes and the valuation allowance on deferred tax assets.
Fair value measurements
When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. The Company has no assets or liabilities that are adjusted to fair value on a recurring basis.
Revenue recognition
Revenue is recorded in accordance with Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“Topic 606”). Revenue is recognized from product sales when goods are shipped, title and risk of loss have transferred to the purchaser, there are no significant vendor obligations, the fees are fixed or determinable, and collection is reasonably assured. Amounts billed to customers for shipping and handling are included in net sales. Costs associated with shipping and handling are included in cost of goods sold. The Company recognizes sales on a gross basis when it is considered the primary obligor in the transaction and on a net basis when it is considered to be acting as an agent. We record estimates for cash discounts, product returns, and other discounts in the period of the sale. This provision is recorded as a reduction from gross sales and the reserves are shown as a reduction of accounts receivable.
Cost of sales
Cost of sales includes inventory costs and shipping and freight expenses.
Basic and diluted earnings per share
Basic earnings per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible note payable. For the three months ended September 30, 2021 and 2020, potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share because they were anti-dilutive are as follows:
|
|
September 30,
|
|
|
September 30,
|
|
|
|
2021
|
|
|
2020
|
|
Warrants
|
|
|
2,563,996
|
|
|
|
8,939,131
|
|
Options
|
|
|
7,280,000
|
|
|
|
5,255,000
|
|
Convertible notes
|
|
|
2,000,000
|
|
|
|
1,000,000
|
|
Total possible dilutive shares
|
|
|
11,843,996
|
|
|
|
15,194,131
|
|
Recent Accounting Pronouncements
Management has considered all recent accounting pronouncements issued and their potential effect on our financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s unaudited condensed consolidated financial statements.
Note 2 – Going Concern
The Company’s unaudited condensed consolidated financial statements are prepared using GAAP, applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. During the three months ended September 30, 2021, the Company had a net loss of $311,355. As of September 30, 2021, the Company had an accumulated deficit of $9,563,029. The Company has not established sufficient revenue to cover its operating costs and will require additional capital to continue its operating plan. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations. These factors raise substantial doubt about its ability to continue as a going concern.
In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plan to obtain such resources for the Company includes: sales of equity instruments; traditional financing, such as loans; and obtaining capital from management and significant stockholders sufficient to meet its minimum operating expenses. However, management cannot provide any assurance that the Company will be successful in accomplishing this plan.
There is no assurance that the Company will be able to obtain sufficient additional funds when needed or that such funds, if available, will be obtainable on terms satisfactory to the Company. In addition, profitability will ultimately depend upon the level of revenues received from business operations. However, there is no assurance that the Company will attain profitability. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
Note 3 – Convertible Notes Payable
Convertible notes – related party
On April 6, 2020, the Company issued convertible note payable of $250,000 with simple interest at 10% per annum if repaid within 90 days, and simple interest at 20% per annum thereafter. The original maturity date of the note was April 6, 2021. The note has been extended for 12 months under the same terms and the new maturity date is April 6, 2022. At the option of holder, this note is convertible at any time which is six months from the date of issuance through that date which is one year from the date of issuance at a conversion price of $0.25per share. In consideration for the loan of $250,000, the Borrower also granted to the Lender 100,000stock options exercisable at $0.25 for a two-year term. The options vested upon issuance. The fair value of the options was $13,297 and was recognized as debt discount as a part of beneficial conversion feature in the year ended June 30, 2020. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $51,594, which is being amortized over the term of the note.
On December 15, 2020, the Company issued convertible note payable of $250,000 with simple interest at 10% per annum if repaid within 90 days, and simple interest at 20% per annum thereafter. The convertible note is due on December 15, 2021. At the option of holder, this note is convertible at any time which is six months from the date of issuance through that date which is one year from the date of issuance at a conversion price of $0.25 per share. In consideration for the loan of $250,000, the Borrower also granted to the Lender 100,000 stock options exercisable at $0.25 for a two-year term. The options vested upon issuance. The fair value of the options was $46,380 and was recognized as debt discount as a part of beneficial conversion feature in the year ended June 30, 2020. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $117,760, which is being amortized over the term of the note.
During the three months ended September 30, 2021 and 2020, amortization of $29,440 and $25,274, respectively ,was recognized as interest expense. As of September 30, 2021 and June 30, 2021, the balance of the notes payable is $500,000 less unamortized debt discount of $19,627 and $49,067, to net $480,373 and $450,933, respectively. Interest expense of $22,917 and $1,958 respectively, was recognized on the convertible notes during the three months ended September 30, 2021 and 2020.
Note 4 – Common stock payable – related party
As of September 30, 2021 and June 30, 2021, the Company reported common stock payable of $477,000, which represents 1,908,000 shares to be issued. Subsequent to September 30, 2021 all of these shares were issued.
Note 5 – Stockholders’ Equity
Common Stock
During the three months ended September 30, 2021, the Company had the following common stock transactions:
|
·
|
300,000 shares issued valued at $30,000 for settlement of debt of $30,000.
|
Stock Purchase Warrants
Transactions in stock purchase warrants for the three months ended September 30, 2021 are as follows:
|
|
Number of
|
|
|
Weighted Average
|
|
|
|
Warrants
|
|
|
Exercise Price
|
|
Balance at June 30, 2021
|
|
|
3,069,329
|
|
|
|
2.27
|
|
Granted
|
|
|
-
|
|
|
|
-
|
|
Exercised – shares issued
|
|
|
-
|
|
|
|
-
|
|
Expired
|
|
|
(505,333
|
)
|
|
|
0.83
|
|
Balance at September 30, 2021
|
|
|
2,563,996
|
|
|
$
|
2.71
|
|
The composition of the Company’s warrants outstanding at September 30, 2021 are as follows:
Exercise Price
|
|
|
Number of Warrants
|
|
|
Weighted Average Remaining Life (in years)
|
|
$
|
0.20
|
|
|
|
100,000
|
|
|
|
1.43
|
|
$
|
0.30
|
|
|
|
349,998
|
|
|
|
2.84
|
|
$
|
0.50
|
|
|
|
666,666
|
|
|
|
2.84
|
|
$
|
1.00
|
|
|
|
708,666
|
|
|
|
2.84
|
|
$
|
1.50
|
|
|
|
20,000
|
|
|
|
0.25
|
|
$
|
2.00
|
|
|
|
718,666
|
|
|
|
2.66
|
|
|
|
|
|
|
2,563,996
|
|
|
|
2.71
|
|
At September 30, 2021, the intrinsic value of the 2,563,996 outstanding warrant was $0.
Stock Options
Transactions in stock options for the three months ended September 30, 2021 are as follows:
|
|
|
|
|
|
|
|
Weighted average
|
|
|
|
Number of
|
|
|
Weighted average
|
|
|
remaining life
|
|
|
|
options
|
|
|
exercise price
|
|
|
(in years)
|
|
Outstanding, June 30, 2021
|
|
|
7,280,000
|
|
|
|
0.23
|
|
|
|
3.76
|
|
Granted
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Expired or Forfeited
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Exercised
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Outstanding, September 30, 2021
|
|
|
7,280,000
|
|
|
|
0.23
|
|
|
|
3.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable, September 30, 2021
|
|
|
6,170,000
|
|
|
$
|
0.24
|
|
|
|
3.30
|
|
During the three months ended September 30, 2021, $73,994 was expensed, of which $29,997 was to related parties, and as of September 30, 2021, $167,992 remains unamortized, of which $79,995 is with related parties.
At September 30, 2021, the intrinsic value of the 7,280,000 outstanding options was $0.
Note 6 – Commitments and Contingencies
On August 1, 2019, the Company entered into an agreement with Stratcon Advisory and Tysadco Partners. Pursuant to the agreement, the Company will pay $6,000 per month for twelve months for corporate development, investment advisory, and investor relations services, payable $3,000 in restricted common stock and $3,000 in cash. During the three months ended September 30, 2021, the Company issued 300,000 shares of common stock at $0.10 per share to settle accounts payable of $30,000. As of September 30, 2021 and June 30, 2021, the Company had a balance of $0 and $30,000 in accounts payable, respectively.
On June 11, 2020, the Company formalized an employment agreement with its chief executive officer which provides for annual salary of $250,000 beginning with the calendar year 2020. The agreement also specified that the CEO would receive $180,000 of salary that was earned during the calendar year 2019. During the three months ended September 30, 2021, compensation expense of $62,500 was recognized under this agreement. The agreement contained provisions for severance, health benefits, and a car allowance.
Note 7 – Subsequent Events
Subsequent to September 30, 2021, the Company issued 1,108,000 shares for stock payable of $277,000.
Subsequent to September 30, 2021, the Company issued a letter of intent to acquire Six 15 Technologies, a technology company that designs, develops, and manufactures head-up displays (HUDs) for enterprise and defense users. The transaction being negotiated is an all-share transaction that will result in the acquirer holding a majority of the shares in the Company.